Management of Dyspnea

Introduction to Dyspnea Management

Opioids are the first-line pharmacological treatment for dyspnea, with sufficient evidence supporting their effectiveness in relieving this distressing symptom, as recommended by the American College of Emergency Physicians and the European Society for Medical Oncology 1, 2

Perform appropriate diagnostic tests to identify reversible causes of dyspnea, such as complete blood count and chest imaging, in patients with dyspnea, as suggested by the European Society for Medical Oncology 2
Address specific underlying conditions before symptomatic treatment, except in emergencies, as recommended by the European Society for Medical Oncology 2
When death is not imminent, treating the etiology of dyspnea is recommended, according to the American College of Emergency Physicians 1

Implement non-pharmacological measures, such as positioning the patient optimally and using cooling methods for the face, before starting medications, as recommended by the European Society for Medical Oncology 2
Provide respiratory training and consider walking aids for patients with dyspnea, as suggested by the European Society for Medical Oncology 2
Educate patients and caregivers about non-pharmacological techniques to reduce helplessness and anxiety, as recommended by the European Society for Medical Oncology 2

Opioids have the strongest evidence base for dyspnea relief and can be used safely in opioid-naïve and opioid-tolerant patients, as recommended by the American College of Emergency Physicians and the European Society for Medical Oncology 1, 2, 3
The recommended dosing for opioids is 2.5-5 mg PO every 4 hours or 1-2.5 mg SC every 4 hours for opioid-naïve patients, as suggested by the European Society for Medical Oncology 4
Avoid morphine in patients with severe renal insufficiency and adjust dosing intervals for all μ-opioids based on renal function, as recommended by the European Society for Medical Oncology 4
Add benzodiazepines when opioids provide insufficient relief, especially when anxiety is present, as recommended by the American College of Emergency Physicians and the European Society for Medical Oncology 1, 4
Consider terminal sedation with benzodiazepines in addition to opioids for refractory dyspnea in dying patients, as recommended by the European Society for Medical Oncology 4

For patients with chronic dyspnea and reduced functional capacity, consider pulmonary rehabilitation and exercise training, as recommended by the American Thoracic Society 5
Non-invasive ventilation techniques should only be used until proper sedation is achieved or when sedation is inadequate, as recommended by the American College of Emergency Physicians 1
Dyspnea is one of the most distressing symptoms in cancer patients and is associated with increased mortality in those with chronic lung disease, as reported by the European Society for Medical Oncology and the American Thoracic Society 2, 5